Evidence map›Paper›PMID 34089229›Full record

ArticleAmerican journal of medical genetics. Part A2021

Risk of sudden cardiac death in EXOSC5-related disease.

Daniel G Calame, Isabella Herman, Jawid M Fatih, Haowei Du, Gulsen Akay, Shalini N Jhangiani, Zeynep Coban-Akdemir, Dianna M Milewicz, Richard A Gibbs, Jennifer E Posey and 5 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in American journal of medical genetics. Part A, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Daniel G CalameDivision of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-6860-372X
Isabella HermanDivision of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-7359-6832
Jawid M FatihDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Haowei DuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Gulsen AkayDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Shalini N JhangianiHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Zeynep Coban-AkdemirDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Dianna M MilewiczDepartment of Internal Medicine, McGovern Medical School, University of Texas Health Center at Houston, Houston, Texas, USA.
Richard A GibbsDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-1356-5698
Jennifer E PoseyDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0003-4814-6765
Dana MarafiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0003-2233-3423
Jill V HunterDepartment of Radiology, Baylor College of Medicine, Houston, Texas, USA.
Yuxin FanJohn Welsh Cardiovascular Diagnostic Laboratory, Departments of Pediatrics and Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.
James R LupskiTexas Children's Hospital, Houston, Texas, USA.ORCID 0000-0001-9907-9246
Christina Y MiyakeDepartment of Pediatrics, Division of Cardiology, Texas Children's Hospital, Houston, Texas, USA.
Baylor College of Medicine · USThe University of Texas Health Science Center · US

Funding

The Human Genome Sequencing CenterU54HG003273 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI GIBBS, RICHARD A · 2004 to 2015
$341.3M
Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
MEDICAL GENETICS RESEARCH FELLOWSHIP PROGRAMT32GM007526 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Brendan Lee · 1985 to 2026
$11.4M
STRUCTURAL VARIATION IN NEUROLOGICAL DISEASER35NS105078 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI LUPSKI, JAMES R. · 2018 to 2025
$6.0M
The Discovery of Novel Genes in Inherited Sudden Arrhythmic Death SyndromesK23HL136932 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MIYAKE, CHRISTINA YUMI · 2018 to 2022
$888k
Individual genomic analyses to discover the molecular basis and mechanisms contributing to adult-onset diseaseK08HG008986 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI POSEY, JENNIFER ELLEN · 2017 to 2021
$831k
NHGRI NIH HHS K08 HG008986NHGRI NIH HHS T32 GM007526-42NHGRI NIH HHS U54 HG003273NHGRI NIH HHS U54HG003273NHGRI NIH HHS UM1 HG006542NHLBI NIH HHS K23 HL136932NHLBI NIH HHS K23HL136932NIGMS NIH HHS T32 GM007526NINDS NIH HHS R35 NS105078NINDS NIH HHS R35NS105078
6 · The paper itself

Abstract

The RNA exosome is a multi-subunit complex involved in the processing, degradation, and regulated turnover of RNA. Several subunits are linked to Mendelian disorders, including pontocerebellar hypoplasia (EXOSC3, MIM #614678; EXOSC8, MIM #616081: and EXOSC9, MIM #618065) and short stature, hearing loss, retinitis pigmentosa, and distinctive facies (EXOSC2, MIM #617763). More recently, EXOSC5 (MIM *606492) was found to underlie an autosomal recessive neurodevelopmental disorder characterized by developmental delay, hypotonia, cerebellar abnormalities, and dysmorphic facies. An unusual feature of EXOSC5-related disease is the occurrence of complete heart block requiring a pacemaker in a subset of affected individuals. Here, we provide a detailed clinical and molecular characterization of two siblings with microcephaly, developmental delay, cerebellar volume loss, hypomyelination, with cardiac conduction and rhythm abnormalities including sinus node dysfunction, intraventricular conduction delay, atrioventricular block, and ventricular tachycardia (VT) due to compound heterozygous variants in EXOSC5: (1) NM_020158.4:c.341C > T (p.Thr114Ile; pathogenic, previously reported) and (2) NM_020158.4:c.302C > A (p.Thr101Lys; novel variant). A review of the literature revealed an additional family with biallelic EXOSC5 variants and cardiac conduction abnormalities. These clinical and molecular data provide compelling evidence that cardiac conduction abnormalities and arrhythmias are part of the EXOSC5-related disease spectrum and argue for proactive screening due to potential risk of sudden cardiac death.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseMutationPhenotypeAntigens, NeoplasmAtrioventricular BlockChildDeath, Sudden, CardiacEchocardiographyElectrocardiographyExosome Multienzyme Ribonuclease ComplexFaciesFemaleHumansMalePedigreeAntigens, NeoplasmEXOSC5 protein, humanExosome Multienzyme Ribonuclease ComplexRNA-Binding ProteinsarrhythmiaEXOSC5exosomeheart blockneurodevelopmental disorders

Identifiers

PMID34089229
PMCPMC8382094
OpenAlexW3165093630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.